Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
86.13
+0.65 (0.76%)
Apr 9, 2026, 4:00 PM EDT - Market closed
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $5.88 billion as of April 10, 2026. Its market cap has increased by 73.17% in one year.
Market Cap
5.88B
Enterprise Value
5.60B
1-Year Change
73.17%
Ranking
Category
Stock Price
$86.13
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $5.88B, an increase of 622.62%. That is a compound annual growth rate of 26.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 5.84B | -18.29% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 6.14B |
| Centessa Pharmaceuticals | 6.11B |
| Terns Pharmaceuticals | 6.08B |
| Cogent Biosciences | 5.95B |
| Mirum Pharmaceuticals | 5.91B |
| PTC Therapeutics | 5.90B |
| CG Oncology | 5.82B |
| Scholar Rock Holding | 5.74B |